OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Allergy and Clinical Immunology-In Practice is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Table of Contents	161
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?	136
Practice Notes from the AAAI	125
The impact of COVID-19 on a national sample of US adults with food allergy	120
Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”	111
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	107
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	106
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	102
Information for Readers	100
March 2023 Practice Notes	85
Managing Atopic Dermatitis in Patients With Skin of Color	84
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	83
Gene Therapy for Inborn Errors of Immunity	80
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	80
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	79
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions	74
CME Exam: Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions	71
Original Article Highlights From This Issue	70
COVID-19 Treatments: Then and Now	69
Original Article Highlights From This Issue	66
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	66
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	64
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps	64
Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation	63
Ask Not What AI Can Do to Us, but What We Can Do with AI	61

Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction	61
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	59
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	59
Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	57
Reducing Health Disparities in Asthma: How Can Progress Be Made	57
Resolution of hypereosinophilic syndrome following resection of a schwannoma	56
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	55
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	55
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	55
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases	54
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	54
Mepolizumab-responsive Kimura disease	54
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	54
Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?	53
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	53
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	52
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	51
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada	51
Chronic norovirus infection in immunodeficiency: A UK national case series	50
Respiratory Diseases Associated With Organic Dust Exposure	50
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	50
Table of Contents	50
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	49
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	48
Respiratory Infections in Patients with Primary Immunodeficiency	48
Information for Readers	48
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	48